DE3583347D1 - Klonieren von dna fuer protozoenantigene. - Google Patents

Klonieren von dna fuer protozoenantigene.

Info

Publication number
DE3583347D1
DE3583347D1 DE8585301173T DE3583347T DE3583347D1 DE 3583347 D1 DE3583347 D1 DE 3583347D1 DE 8585301173 T DE8585301173 T DE 8585301173T DE 3583347 T DE3583347 T DE 3583347T DE 3583347 D1 DE3583347 D1 DE 3583347D1
Authority
DE
Germany
Prior art keywords
protozone
antigens
cloning dna
cloning
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585301173T
Other languages
English (en)
Inventor
Anthony Arthur Holder
Jasbir Singh Sandhu
Karel Gerrit Odink
Michael James Lockyer
Valentina Riveros-Moreno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848404692A external-priority patent/GB8404692D0/en
Priority claimed from GB848424340A external-priority patent/GB8424340D0/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of DE3583347D1 publication Critical patent/DE3583347D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE8585301173T 1984-02-22 1985-02-21 Klonieren von dna fuer protozoenantigene. Expired - Lifetime DE3583347D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848404692A GB8404692D0 (en) 1984-02-22 1984-02-22 Cloning of dna for protozoal antigens
GB848424340A GB8424340D0 (en) 1984-09-26 1984-09-26 Cloning of dna

Publications (1)

Publication Number Publication Date
DE3583347D1 true DE3583347D1 (de) 1991-08-08

Family

ID=26287348

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585301173T Expired - Lifetime DE3583347D1 (de) 1984-02-22 1985-02-21 Klonieren von dna fuer protozoenantigene.

Country Status (14)

Country Link
US (1) US5597708A (de)
EP (1) EP0154454B1 (de)
JP (2) JP2584733B2 (de)
AT (1) ATE64957T1 (de)
AU (1) AU592749B2 (de)
CA (1) CA1340103C (de)
DE (1) DE3583347D1 (de)
DK (1) DK79985A (de)
GB (1) GB2154592A (de)
HU (1) HU200794B (de)
IL (1) IL74409A (de)
NZ (1) NZ211191A (de)
PH (1) PH25993A (de)
ZW (1) ZW2485A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU584881B2 (en) * 1984-02-21 1989-06-08 British Technology Group Limited Improvements in or relating to the production of malaria vaccines
IL76338A (en) * 1984-09-11 1994-08-26 Saramane Pty Ltd Plasmodium plasmodium immunogenic polypeptides, AND molecules encoding them, a method for preparing the polypeptides and preparations containing the polypeptide
EP0217877A4 (de) * 1985-04-11 1988-03-30 Inst Medical W & E Hall Sehr wiederholungsfähige antigene von plasmodium falciparum.
US4978621A (en) * 1985-09-03 1990-12-18 Scripps Clinic And Research Foundation Merozoite surface antigens
JPS63502002A (ja) * 1985-12-24 1988-08-11 ザ・ワルタ−・アンド・エリザ・ホ−ル・インスティテュ−ト・オヴ・メディカル・リサ−チ 無性の血中段階におけるプラズモジウム・ファルシパルムの抗原
EP0252588A3 (de) * 1986-05-12 1989-07-12 Smithkline Beecham Corporation Verfahren zur Isolierung und Reinigung von P. falciparum CS-Protein in rekombinantem E. coli sowie seine Verwendung als Impfstoff
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
GB8706599D0 (en) * 1987-03-19 1987-04-23 Hoffmann La Roche Plasmodium falciparum merozoite antigen peptides
DE3737238A1 (de) * 1987-11-03 1989-05-18 Behringwerke Ag Rekombinantes histidinreiches protein (37 kd antigen) von plasmodium falciparum, seine herstellung und verwendung
AT388934B (de) * 1987-11-13 1989-09-25 Wellcome Found Rekombinationskonjugatprotein und neue vakzinen
DE3831351A1 (de) * 1987-12-30 1989-07-13 Behringwerke Ag Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung
US6333406B1 (en) 1988-08-12 2001-12-25 Joseph W. Inselburg Gene encoding protein antigens of Plasmodium falciparum and uses therefor
US5756101A (en) * 1991-07-01 1998-05-26 Pasteur Merieux Serums Et Vaccins Malaria recombinant poxvirus
US6855316B1 (en) * 1994-02-14 2005-02-15 University Of Hawaii Baculovirus produced Plasmodium falciparum vaccine
FR2744723A1 (fr) * 1996-02-14 1997-08-14 Pasteur Institut Proteine recombinante contenant un fragment c-terminal d'une proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
FR2744724B1 (fr) * 1996-02-14 2002-08-02 Pasteur Institut Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
DE19640817A1 (de) 1996-10-02 1998-05-14 Hermann Prof Dr Bujard Rekombinantes Herstellungsverfahren für ein vollständiges Malaria-Antigen gp190/MSP 1
MY140679A (en) 2001-05-24 2010-01-15 Avanir Pharmaceuticals Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
US20040082048A1 (en) * 2002-10-15 2004-04-29 Viswanath Nittala Venkata Narasimha Genes and protein sequences useful as drug targets for therapeutic action against protozoa
TW200418829A (en) * 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AU2004268941A1 (en) * 2003-08-22 2005-03-10 Avanir Pharmaceuticals Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
AU2006227297A1 (en) 2005-03-24 2006-09-28 Avanir Pharmaceuticals Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
GB0605689D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
US7931908B2 (en) 2007-02-23 2011-04-26 Philadelphia Health Education Corporation Chimeric MSP-based malaria vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
IL65496A (en) * 1981-04-15 1985-10-31 Wellcome Found Protozoal antigen,its preparation and vaccine containing it
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
GB8404378D0 (en) * 1984-02-20 1984-03-28 Biogen Nv Dna sequence recombinant dna molecules

Also Published As

Publication number Publication date
IL74409A0 (en) 1985-05-31
JPH06189772A (ja) 1994-07-12
DK79985A (da) 1985-08-23
ZW2485A1 (en) 1986-09-24
US5597708A (en) 1997-01-28
JPS6119490A (ja) 1986-01-28
IL74409A (en) 1994-08-26
CA1340103C (en) 1998-10-27
AU3904685A (en) 1985-09-05
EP0154454B1 (de) 1991-07-03
DK79985D0 (da) 1985-02-21
HUT37460A (en) 1985-12-28
HU200794B (en) 1990-08-28
EP0154454A1 (de) 1985-09-11
ATE64957T1 (de) 1991-07-15
JP2893626B2 (ja) 1999-05-24
PH25993A (en) 1992-01-13
GB8504429D0 (en) 1985-03-27
GB2154592A (en) 1985-09-11
AU592749B2 (en) 1990-01-25
NZ211191A (en) 1988-01-08
JP2584733B2 (ja) 1997-02-26

Similar Documents

Publication Publication Date Title
DE3583347D1 (de) Klonieren von dna fuer protozoenantigene.
DE69133389D1 (de) Direkte Klonierung von PCR amplifizierten Nukleinsäuren
DE3587394D1 (de) Rekombinante virusproteine begleitet von lymphadenopathischem syndrom und/oder "acquired immune deficiency syndrome" (aids).
HU9200548D0 (en) Improved activity process of recombined proteins
DE3853139D1 (de) Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
DE3877428D1 (de) Kondensationsprodukte von silanol, deren herstellung und verwendungen.
DK480685D0 (da) Dna-sekvenser, rekombinant-dna samt fremgangsmaader til fremstilling af antigener af plasmodium falciparum
DE3684650D1 (de) Klonierung und charakterisierung des rinder-interleukin-2-gens.
PT84850A (en) Process for isolating and purifying p.falciparum cs protein vaccine expressed in recombinant e.coli
KR890013181A (ko) 플라스모듐 팔시파럼(plasmodium falciparum)의 주위 포자소체 유전자로부터 유도된 재조합 단백질의 제조방법
DE3880520D1 (de) Rekombinantes plasmid fuer die expression von l-phenylalanin-ammonialyase und transformierte staemme, die es enthalten.
DE3765784D1 (de) Zusammensetzung von aminosaeuren.
DE3881123D1 (de) Klonieren von fuer einen antibakteriellen polypeptidvorlaeufer kodierender dna und expression des vorlaeufers.
DE69130895D1 (de) 16-kDa-OBERFLÄCHENPROTEIN VON P. FALCIPARUM
ATE70979T1 (de) Plasmodium-falciparum-antigene der intraerythrocytaeren phase, ihre reinigung sowie antigen- und antikoerperbestimmung und sie enthaltende malaria-impfstoffe.
ATE188997T1 (de) Klonierung von malaria-spezifischen dna- sequenzen:isolierung des gens für das 140 kd protein
NZ233255A (en) Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
ATE61818T1 (de) Dns-sequenzen, rekombinante dns und verfahren zur herstellung von plasmodium-falciparumantigenen.
ATE84315T1 (de) Rekombinante dna zur reprimierbaren und induzierbaren expression von fremdgenen.
DE3873255D1 (de) Methoden und praeparate zur vorbeugung von ulcera.
IT8821123A0 (it) Clonaggio del gene che codifica l'enzima isoamilasi e suo impiego per la produzione di detto enzima o suoi analoghi.
IT8821282A0 (it) Clonaggio del gene che codifica l'enzima isoamilasi e suo impiego per la produzione di detto enzima o suoi analoghi.
DE3770214D1 (de) Sessel zur bedienung von kunden.
ATE78694T1 (de) Methoden und praeparate zur vorbeugung von ulcera.
NO880080L (no) Fremgangsmaate for isolering og rensing av p.faliciparum cs-proteinvaksine uttrykt i rekombinant e.coli.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition